Sep 22, 2026 · 6 min
Alibaba’s chip ambitions meet export-control reality
Alibaba and ON Climb; Quest Slides
The episode shows how product plans, growth forecasts, and policy changes are reshaping expectations across technology, consumer brands, and healthcare stocks.
- 1Alibaba is positioning a new data-center chip against Nvidia, but U.S. export controls could constrain production at scale.
- 2On Holdings projects high-teens sales growth as it expands beyond running into golf and soccer.
- 3Quest Diagnostics faces revenue pressure from proposed Medicare lab-payment cuts designed to reduce government spending.
Don't miss
Alibaba’s chip story captures the episode’s central tension: stronger technology ambitions colliding with export controls that could limit production.
The brief
The Stock Movers Report surveys a market split between company execution and outside constraints, from Thor Industries’ mixed quarter to proposed Medicare cuts affecting laboratory providers.
Dan Curtis discusses Thor Industries, which beat sales estimates but missed earnings expectations while forecasting a relatively flat environment for the coming year.
Alibaba says its new data-center chip delivers substantially improved performance versus earlier products and competes with Nvidia, but U.S. export controls may limit manufacturing scale.
On Holdings forecasts high-teens sales growth under a new three-year plan, using expansion into golf and soccer—and partnerships with Roger Federer and Kylian Mbappé—to broaden its reach.
Quest Diagnostics and other labs face pressure from preliminary Medicare rates expected to reduce government spending by about $1 billion, implying lower provider revenue.
What was said on this episode
3 statements · 3 negative
Thor Industries’ quarterly EPS missed Wall Street expectations by nine cents
“earnings per share came at 78 cents per share. That was nine pennies short of what Wall Street was expecting”
Listen at 1:10
U.S. export controls largely block Chinese firms from using TSMC production lines
“the U.S. has export controls that largely block Chinese firms from using market leaders like TSMC in the production lines”
Listen at 2:12
Medicare savings imply lower revenue for laboratory companies
“savings from them is less money for the lab companies”
Listen at 4:28
Statements are attributed to the speaker as said on the episode and reflect their view at the time, not PodLume's. They are not advice.
Featuring
Nvidia Corporation
Thor Industries
Bloomberg L.P.Listen to the full episode and explore every guest, topic, and moment on PodLume.